New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new Innovative Medicines Initiative Call for proposals.
Commission R&D funding for neglected diseases rose by 50 per cent in 2017. The UK and US remain the biggest funders - and UK spending increased by 89 per cent, says Australian charity
A leading geneticist recounts the story of one rogue scientist, and the damage he caused. ‘He should be stopped from doing anything like this again,’ says Robin Lovell-Badge
Some medicines may carry a higher risk of side effects for the lungs than previously thought, IMI research reveals. The drugs studied work well for most, but doctors should monitor patients for side effects.
Spain is widely regarded as having one of the world’s best healthcare systems. Can a series of experiments in ‘value-based’ care help to make it even better? A new Science|Business report finds out
In a new series of videos released during IMI’s 10th anniversary, IMI project participants from universities, patient groups, SMEs and the pharmaceutical industry explain how they are benefiting from participating in IMI projects and how they think IMI is changing medical research.
In a new series of videos released during IMI’s 10th anniversary, IMI project participants from universities, patient groups, SMEs and the pharmaceutical industry explain how they are benefiting from participating in IMI projects and how they think IMI is changing medical research.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.